Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Oct-24 7:40 PM View:  | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 14-Oct-24 | Option Sale | 119 | $10.15 | $1,207.86 | (< 1%) 25.53K to 25.41K | |
| 15-Oct-24 7:40 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Oct-24 | Option Exercise | 335 | -- | -- | 1% 25.19K to 25.53K | |
| 11-Oct-24 7:37 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-24 | Option Sale | 17,173 | $10.05 | $172,589.00 | (7%) 243.83K to 226.65K | |
| 11-Oct-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-24 | Option Sale | 2,031 | $10.05 | $20,411.60 | (4%) 47.15K to 45.12K | |
| 11-Oct-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-24 | Option Sale | 201 | $10.05 | $2,020.05 | (< 1%) 45.12K to 44.92K | |
| 11-Oct-24 7:38 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-24 | Option Sale | 982 | $10.05 | $9,869.10 | (4%) 26.17K to 25.19K | |
| 11-Oct-24 7:38 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-24 | Option Exercise | 2,763 | -- | -- | 12% 23.41K to 26.17K | |
| 11-Oct-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-24 | Option Exercise | 5,506 | -- | -- | 13% 41.19K to 46.69K | |
| 11-Oct-24 7:37 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-24 | Option Exercise | 31,512 | -- | -- | 15% 212.31K to 243.83K | |
| 11-Oct-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-24 | Option Exercise | 462 | -- | -- | < 1% 46.69K to 47.15K | |
| 16-Jul-24 7:50 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 15-Jul-24 | Option Sale | 530 | $8.36 | $4,430.80 | (1%) 41.72K to 41.19K | |
| 16-Jul-24 7:48 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 15-Jul-24 | Option Sale | 307 | $8.36 | $2,566.52 | (1%) 23.72K to 23.41K | |
| 16-Jul-24 7:50 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Jul-24 | Option Exercise | 1,469 | -- | -- | 4% 40.25K to 41.72K | |
| 15-Jul-24 4:40 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Jul-24 | Option Sale | 119 | $8.05 | $957.95 | (< 1%) 22.95K to 22.84K | |
| 16-Jul-24 7:48 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Jul-24 | Option Exercise | 881 | -- | -- | 4% 22.84K to 23.72K | |
| 15-Jul-24 4:40 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Jul-24 | Option Exercise | 335 | -- | -- | 1% 22.62K to 22.95K | |
| 12-Jul-24 4:30 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Jul-24 | Option Sale | 1,456 | $7.54 | $10,978.20 | (3%) 41.76K to 40.31K | |
| 12-Jul-24 4:30 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Jul-24 | Option Sale | 59 | $7.54 | $444.86 | (< 1%) 40.31K to 40.25K | |
| 12-Jul-24 4:30 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Exercise | 135 | -- | -- | < 1% 41.63K to 41.76K | |
| 11-Jul-24 5:01 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Sale | 444 | $7.54 | $3,347.76 | (2%) 23.06K to 22.62K | |
| 11-Jul-24 5:02 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Sale | 115 | $7.54 | $867.10 | (< 1%) 37.7K to 37.58K | |
| 11-Jul-24 5:00 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Sale | 7,657 | $7.54 | $57,733.80 | (3%) 219.97K to 212.31K | |
| 12-Jul-24 4:30 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Exercise | 4,047 | -- | -- | 11% 37.58K to 41.63K | |
| 11-Jul-24 5:02 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-24 | Option Sale | 910 | $7.54 | $6,861.40 | (2%) 38.6K to 37.7K | |
| 11-Jul-24 5:00 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-24 | Option Exercise | 14,400 | -- | -- | 7% 205.57K to 219.97K | |
| 11-Jul-24 5:02 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-24 | Option Exercise | 2,512 | -- | -- | 7% 35.84K to 38.35K | |
| 11-Jul-24 5:01 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-24 | Option Exercise | 1,267 | -- | -- | 6% 21.8K to 23.06K | |
| 11-Jul-24 5:02 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-24 | Option Exercise | 255 | -- | -- | < 1% 38.35K to 38.6K | |
| 11-Jul-24 5:00 PM View: | Alegria Esther M. Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-24 | Option Exercise | 689 | -- | -- | 7% 10.3K to 10.99K | |
| 02-Jul-24 7:32 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-24 | Acquisition (other) | 1,965 | $5.41 | $10,622.80 | 3% 64.83K to 66.8K | |
| 02-Jul-24 7:32 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-24 | Acquisition (other) | 1,965 | $5.41 | $10,622.80 | 6% 32.48K to 34.45K | |
| 02-Jul-24 7:32 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-24 | Acquisition (other) | 1,965 | $5.41 | $10,622.80 | 2% 82.22K to 84.19K | |
| 02-Jul-24 7:32 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-24 | Acquisition (other) | 1,965 | $5.41 | $10,622.80 | < 1% 203.61K to 205.57K | |
| 02-Jul-24 7:32 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-24 | Acquisition (other) | 1,388 | $5.41 | $7,503.53 | 4% 34.45K to 35.84K | |
| 02-May-24 8:21 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 109 | $7.40 | $806.60 | (< 1%) 32.59K to 32.48K | |
| 02-May-24 8:20 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 2,826 | $7.40 | $20,910.40 | (3%) 85.05K to 82.22K | |
| 02-May-24 8:20 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 11,762 | $7.40 | $87,028.20 | (5%) 215.37K to 203.61K | |
| 02-May-24 8:21 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 1,643 | $7.40 | $12,157.00 | (2%) 66.48K to 64.83K | |
| 02-May-24 8:21 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 1,005 | $7.40 | $7,436.50 | (3%) 33.6K to 32.59K | |
| 02-May-24 8:20 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 30-Apr-24 | Sale | 1,233 | $7.40 | $9,121.98 | (5%) 23.03K to 21.8K | |
| 12-Apr-24 7:35 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Apr-24 | Option Exercise | 669 | -- | -- | 3% 22.36K to 23.03K | |
| 11-Apr-24 7:40 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 22,877 | -- | -- | 12% 192.49K to 215.37K | |
| 11-Apr-24 7:43 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 2,512 | -- | -- | 8% 30.83K to 33.34K | |
| 11-Apr-24 7:42 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 2,532 | -- | -- | 13% 19.83K to 22.36K | |
| 11-Apr-24 7:41 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 5,742 | -- | -- | 7% 79.31K to 85.05K | |
| 11-Apr-24 7:43 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 254 | -- | -- | < 1% 33.34K to 33.6K | |
| 11-Apr-24 7:44 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 3,208 | -- | -- | 5% 63.27K to 66.48K | |
| 12-Jan-24 7:34 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Jan-24 | Option Sale | 274 | $6.77 | $1,854.98 | (1%) 20.1K to 19.83K | |
| 12-Jan-24 7:34 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Jan-24 | Option Exercise | 669 | -- | -- | 3% 19.43K to 20.1K | |
| 11-Jan-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 1,055 | $6.17 | $6,509.35 | (3%) 32.0K to 30.95K |
